You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
| Title |
An Improved CRISPR/dCas9 Interference Tool for Neuronal Gene Suppression
|
|---|---|
| Published in |
Frontiers in Genome Editing, September 2020
|
| DOI | 10.3389/fgeed.2020.00009 |
| Pubmed ID | |
| Authors |
Corey G. Duke, Svitlana V. Bach, Jasmin S. Revanna, Faraz A. Sultan, Nicholas T. Southern, M. Natalie Davis, Nancy V. N. Carullo, Allison J. Bauman, Robert A. Phillips, Jeremy J. Day |
X Demographics
The data shown below were collected from the profiles of 56 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 31 | 55% |
| Canada | 2 | 4% |
| Switzerland | 1 | 2% |
| Italy | 1 | 2% |
| Brazil | 1 | 2% |
| France | 1 | 2% |
| Germany | 1 | 2% |
| Czechia | 1 | 2% |
| Unknown | 17 | 30% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 27 | 48% |
| Scientists | 26 | 46% |
| Practitioners (doctors, other healthcare professionals) | 3 | 5% |
Mendeley readers
The data shown below were compiled from readership statistics for 96 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 96 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Ph. D. Student | 18 | 19% |
| Student > Bachelor | 11 | 11% |
| Student > Master | 8 | 8% |
| Researcher | 7 | 7% |
| Student > Doctoral Student | 4 | 4% |
| Other | 11 | 11% |
| Unknown | 37 | 39% |
| Readers by discipline | Count | As % |
|---|---|---|
| Biochemistry, Genetics and Molecular Biology | 18 | 19% |
| Neuroscience | 13 | 14% |
| Agricultural and Biological Sciences | 7 | 7% |
| Medicine and Dentistry | 4 | 4% |
| Pharmacology, Toxicology and Pharmaceutical Science | 2 | 2% |
| Other | 11 | 11% |
| Unknown | 41 | 43% |